Changes in HLA-DR expression, cytokine production and coagulation following endotoxin infusion in healthy human volunteers

Int Immunopharmacol. 2008 May;8(5):701-7. doi: 10.1016/j.intimp.2008.01.014. Epub 2008 Feb 11.

Abstract

The infusion of a low dose of endotoxin into healthy subjects triggers a complex inflammatory response but the intricacies of which, despite extensive research, are still being unraveled. Nine healthy male volunteers received a dose of 30 Units endotoxin/kg bodyweight as an intravenous bolus. Following endotoxin infusion the concentration of TNF-alpha in their serum rapidly increased within 30 min, peaked after 1-2 h and returned to baseline by 4 h. This corresponded to a similarly rapid increase in anti-inflammatory soluble TNF receptor (sTNFR) levels, which remained elevated for up to 48 h. Increased levels of other cytokines were measured, including IL-6, IL-8, G-CSF, IL-1ra and IL-10. However, these cytokines lagged behind that of TNF-alpha and remained elevated for up to 8 h. Endotoxin injection resulted in complex changes in HLA-DR expression, a marker of monocyte activation state. Initially, following a lag of 2-4 h, HLA-DR expression decreased with a nadir at 8 h, followed by an increase in expression above baseline at 22 h. HLA-DR levels returned to baseline 48 h post-endotoxin challenge. This was in contrast to endotoxin-induced changes in white blood cell (WBC) numbers, which dropped rapidly (at 2-3 h) while HLA-DR levels were stable and then peaked during the nadir in HLA-DR expression (8 h). Furthermore, endotoxin injection caused activation of both fibrinolytic and coagulation pathways. Thus, endotoxin infusion results in complex changes in HLA-DR expression, production of pro- and anti-inflammatory cytokines and activation of coagulation.

MeSH terms

  • Antithrombins / metabolism
  • Blood Coagulation / drug effects*
  • C-Reactive Protein / metabolism
  • Cytokines / biosynthesis*
  • Cytokines / genetics
  • Electrocardiography / drug effects
  • Endotoxins / toxicity*
  • Fibrinolysis / drug effects
  • Granulocyte Colony-Stimulating Factor / metabolism
  • HLA-DR Antigens / biosynthesis*
  • HLA-DR Antigens / genetics
  • Humans
  • Leukocyte Count
  • Lipopolysaccharides / pharmacology
  • Liver Function Tests
  • Partial Thromboplastin Time

Substances

  • Antithrombins
  • Cytokines
  • Endotoxins
  • HLA-DR Antigens
  • Lipopolysaccharides
  • Granulocyte Colony-Stimulating Factor
  • endotoxin, Escherichia coli
  • C-Reactive Protein